These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35298396)

  • 1. The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings.
    Regazzo D; Bertazza L; Galletta E; Barollo S; Mondin A; Zovato S; Iacobone M; Zilio E; Scaroni C; Radu CM; di Benedetto G; Mian C; Lefkimmiatis K; Occhi G
    Endocr Relat Cancer; 2022 Apr; 29(5):273-284. PubMed ID: 35298396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
    Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
    Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of
    Regazzo D; Losa M; Albiger NM; Terreni MR; Vazza G; Ceccato F; Emanuelli E; Denaro L; Scaroni C; Occhi G
    Eur J Endocrinol; 2017 May; 176(5):543-553. PubMed ID: 28179449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
    Buhren BA; Gasis M; Thorens B; Müller HW; Bosse F
    J Neurosci Res; 2009 Jun; 87(8):1858-70. PubMed ID: 19170165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
    Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
    J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked cortisol production by intracrine ACTH in GIP-treated cultured adrenal cells in which the GIP receptor was exogenously introduced.
    Fujii H; Tamamori-Adachi M; Uchida K; Susa T; Nakakura T; Hagiwara H; Iizuka M; Okinaga H; Tanaka Y; Okazaki T
    PLoS One; 2014; 9(10):e110543. PubMed ID: 25334044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistin knockout mice exhibit impaired adipocyte glucose-dependent insulinotropic polypeptide receptor (GIPR) expression.
    Kim SJ; Nian C; McIntosh CH
    Diabetes; 2013 Feb; 62(2):471-7. PubMed ID: 23002036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model.
    Weaver RE; Donnelly D; Wabitsch M; Grant PJ; Balmforth AJ
    Int J Obes (Lond); 2008 Nov; 32(11):1705-11. PubMed ID: 18779825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice.
    Harada N; Yamada Y; Tsukiyama K; Yamada C; Nakamura Y; Mukai E; Hamasaki A; Liu X; Toyoda K; Seino Y; Inagaki N
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E61-8. PubMed ID: 17971513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GIP-GIPR promotes neurite outgrowth of cortical neurons in Akt dependent manner.
    Teng L; Guan T; Guo B; Ma C; Lin G; Wu R; Xu M; Liu M; Liu Y
    Biochem Biophys Res Commun; 2021 Jan; 534():121-127. PubMed ID: 33321289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation.
    Song DH; Getty-Kaushik L; Tseng E; Simon J; Corkey BE; Wolfe MM
    Gastroenterology; 2007 Dec; 133(6):1796-805. PubMed ID: 18054552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular biology of the GIP receptor.
    Greenwell AA; Chahade JJ; Ussher JR
    Peptides; 2020 Mar; 125():170228. PubMed ID: 31812593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
    Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
    Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human GIP(3-30)NH
    Gabe MBN; Sparre-Ulrich AH; Pedersen MF; Gasbjerg LS; Inoue A; Bräuner-Osborne H; Hartmann B; Rosenkilde MM
    Biochem Pharmacol; 2018 Apr; 150():97-107. PubMed ID: 29378179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GIP receptor: Expression in neuroendocrine tumours, internalization, signalling from endosomes and structure-function relationship studies.
    Reubi JC; Fourmy D; Cordomi A; Tikhonova IG; Gigoux V
    Peptides; 2020 Mar; 125():170229. PubMed ID: 31857104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
    Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of GIP in α-cells and glucagon secretion.
    El K; Campbell JE
    Peptides; 2020 Mar; 125():170213. PubMed ID: 31785304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptor.
    Yuliantie E; van der Velden WJC; Labroska V; Dai A; Zhao F; Darbalaei S; Deganutti G; Xu T; Zhou Q; Yang D; Rosenkilde MM; Sexton PM; Wang MW; Wootten D
    Biochem Pharmacol; 2021 Oct; 192():114715. PubMed ID: 34339714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.
    Ravn P; Madhurantakam C; Kunze S; Matthews E; Priest C; O'Brien S; Collinson A; Papworth M; Fritsch-Fredin M; Jermutus L; Benthem L; Gruetter M; Jackson RH
    J Biol Chem; 2013 Jul; 288(27):19760-72. PubMed ID: 23689510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping interactions of gastric inhibitory polypeptide with GIPR N-terminus using NMR and molecular dynamics simulations.
    Tikhele SH; Pissurlenkar RR; Srivastava S; Saran A; Coutinho EC
    J Pept Sci; 2010 Aug; 16(8):383-91. PubMed ID: 20607844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.